SABS compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name

SABSSAB Biotherapeutics, Inc.

Mkt capRevenueRevenue

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

Compare

SABSSAB Biotherapeutics, Inc.

IRDOpus Genetics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SABS: latest quarter is a loss; flow not drawable. IRD: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SABS 5

EBSEmergent BioSolutions Canadasupplier

—Avance Clinical PTY, Ltd ("Avance")unlistedsupplier

—Fortrea Holdings Inc. ("Fortrea")unlistedsupplier

—Sanford Applied Biosciencesunlistedsupplier

1 more · SABS chain ›

Shared 0

No shared counterparties.

Only IRD 4

VTRSViatrissupplier

—FDA Office of Orphan Drug Productsunlistedsupplier

—Foundation Fighting Blindnessunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

National Institutes of Health

unlistedsupplier

Price

rebased to 0%

SABS, solidIRD, dashed

SABSSAB Biotherapeutics, Inc.

3.34▲+3.39%· post 3.34

Mkt cap$304.8MRevenue$114,698Q4 FY24Revenue—

IRDOpus Genetics, Inc.

3.67▲+0.44%· post 3.64

ClosedOct 30 '26

Mkt cap$305.3MRevenue$755,000Q2 FY26Revenue$14MFY25

Compare

ClosedOct 30 '26

SABSSAB Biotherapeutics, Inc.

IRDOpus Genetics, Inc.

3.34▲+3.39%post 3.34

Price

3.67▲+0.44%post 3.64

$304.8M

Mkt cap

$305.3M

Q4 FY24$114,698

Revenue

$755,000Q2 FY26

—

Revenue

$14MFY25

SABS3.34▲+3.39%vsIRD3.67▲+0.44%ClosedOct 30 '26